Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression-Reference-Cited by-同舟云学术

Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression

Published:2011-06 Issue:6 Volume:19 Page:715-727
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Schmid Michael C.,Avraamides Christie J.,Dippold Holly C.,Franco Irene,Foubert Philippe,Ellies Lesley G.,Acevedo Lissette M.,Manglicmot Joan R.E.,Song Xiaodan,Wrasidlo Wolfgang,Blair Sara L.,Ginsberg Mark H.,Cheresh David A.,Hirsch Emilio,Field Seth J.,Varner Judith A.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference48 articles.

1. Integrin structure, allostery, and bidirectional signaling;Arnaout;Annu. Rev. Cell Dev. Biol.,2005

2. Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III;Bergmeier;J. Clin. Invest.,2007

3. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm;Biswas;Nat. Immunol.,2010

4. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells;Bronte;Blood,2000

5. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression;Bunt;J. Immunol.,2006

Cited by 344 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Pyrazolo[1,5-a]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors;Journal of Medicinal Chemistry;2024-08-20

2. IL-13 and IL-17A activate β1 integrin through an NF-kB/Rho kinase/PIP5K1γ pathway to enhance force transmission in airway smooth muscle;Proceedings of the National Academy of Sciences;2024-08-13

3. Targeting PI3K-gamma in myeloid driven tumour immune suppression: a systematic review and meta-analysis of the preclinical literature;Cancer Immunology, Immunotherapy;2024-08-06

4. Dissection of triple-negative breast cancer microenvironment and identification of potential therapeutic drugs using single-cell RNA sequencing analysis;Journal of Pharmaceutical Analysis;2024-08

5. Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment;Journal for ImmunoTherapy of Cancer;2024-08